Stay informed on issues important to patients of Montgomery Cancer Center.
Montgomery Cancer Center among first in nation to treat advanced prostate cancer patients with Provenge
Montgomery Cancer Center is the first facility in Alabama and among the first in the nation to treat advanced prostate cancer patients with a promising new therapy. Read More
Fri, 18 May 2012 00:01:11 +0000
Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three studies published in the New England Journal of Medicine. Multiple myeloma is a cancer of plasma cells, which are a special type of white blood cell that are part [...]
read more |
The most state-of-the-art technology of its kind in Alabama, TrueBeam™ from Varian Medical Systems integrates advanced imaging and motion management technologies to target tumors with sub-millimeter accuracy – and short treatment times. |
Take a minute to visit the campus of Montgomery Cancer Center - without leaving your computer. Take a tour.
Stephen L. Davidson, M.D.
Stephen L. Davidson, M.D., is the medical oncologist and hematologist as well as a partner at Montgomery Cancer Center. He is also the medical director of clinical research, and a clinical assistant professor of medicine at the University of Alabama School of Medicine in Birmingham. A graduate of both Samford University and the University of Alabama School of Medicine of Internal Medicine for internal medicine....
